EUVIMEDEUVIMED entdecken
FallberichtÜbersichtsarbeit

Infantile posterior fossa atypical teratoid/rhabdoid tumor: navigating diagnostic complexity and molecular paradigms

Sukhrob A Tashmatov, Bahodir A Ruzinazarov

Child's Nervous System · 29.10.2026 · 42 (1)

DOI: 10.1007/s00381-026-07497-1 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Child's Nervous System, online erschienen am 29.10.2026. Verfasst von Sukhrob A Tashmatov und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, National Children's Medical Center, Tashkent, Uzbekistan. tashmatov-med@mail.ru. Hauptthemen laut MEDLINE: Rhabdoid Tumor, Teratoma, Infratentorial Neoplasms. Die Arbeit nennt 20 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Atypical teratoid/rhabdoid tumor (AT/RT) is an exceptionally aggressive, SWI/SNF-deficient embryonal neoplasm that poses profound diagnostic and therapeutic challenges, particularly in infants. We present the case of a female infant under 1 year of age harboring a massive, cystic-solid AT/RT of the posterior cranial fossa. The clinical trajectory was complicated by rapid-onset obstructive hydrocephalus, necessitating urgent cerebrospinal fluid diversion prior to gross total microsurgical resection. Definitive diagnosis was established via comprehensive neuropathological evaluation, highlighting a robust rhabdoid histomorphology, an elevated Ki-67 index, and the pathognomonic complete loss of SMARCB1 (INI1) nuclear expression. This report meticulously details the morphological and immunohistochemical profiling required to differentiate AT/RT from medulloblastoma and ependymoma in the infantile demographic. Furthermore, we contextualize these findings within the 2021 WHO Classification of CNS Tumors, discussing the imperative of identifying specific molecular subgroups (TYR, SHH, MYC) and the necessity of screening for Rhabdoid Tumor Predisposition Syndrome. Finally, we review contemporary adjuvant strategies, emphasizing the transition from conventional neurotoxic regimens toward targeted epigenetic therapies, such as EZH2 inhibition, in the pediatric population.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Rhabdoid TumorTeratomaInfratentorial NeoplasmsHumansFemaleInfantSMARCB1 Protein

Stichwörter der Autor:innen

Atypical teratoid/rhabdoid tumorEZH2 inhibitorsINI1Infant neuro-oncologyPosterior cranial fossaSMARCB1

Substanzen

SMARCB1 ProteinSMARCB1 protein, human

Autor:innen und Institutionen

  • Department of Pathology, National Children's Medical Center, Tashkent, Uzbekistan. tashmatov-med@mail.ru.
  • Department of Pathology, National Children's Medical Center, Tashkent, Uzbekistan.

Zitieren

APA

Tashmatov, S. A., & Ruzinazarov, B. A. (2026). Infantile posterior fossa atypical teratoid/rhabdoid tumor: navigating diagnostic complexity and molecular paradigms. Child's Nervous System, 42(1). https://doi.org/10.1007/s00381-026-07497-1

Vancouver

Tashmatov SA, Ruzinazarov BA. Infantile posterior fossa atypical teratoid/rhabdoid tumor: navigating diagnostic complexity and molecular paradigms. Child's Nervous System. 2026;42(1). doi:10.1007/s00381-026-07497-1

BibTeX
@article{Tashmatov2026,
  author = {Tashmatov, Sukhrob A and Ruzinazarov, Bahodir A},
  title = {Infantile posterior fossa atypical teratoid/rhabdoid tumor: navigating diagnostic complexity and molecular paradigms},
  journal = {Child's Nervous System},
  year = {2026},
  volume = {42},
  number = {1},
  doi = {10.1007/s00381-026-07497-1}
}
Kostenlos starten →